Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Pete Rathburn is a copy editor and fact-checker with expertise in ...
The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback